Classifying diabetes according to the new WHO clinical stages
The DOI matches its Crossref record; 12 of the 13 references it cites were found in a registry or an index.
Abstract
Aims/hypothesis To test the usefulness of the new WHO criteria for clinical staging of diabetes in the characterization of 1977 diabetic patients. Methods The following clinical stages were used: patients on diet and/or oral antidiabetic agents 2 years after diagnosis were considered as non-insulin requiring (NIR; n = 711) and patients who required insulin therapy after 1 year as insulin requiring for control (IRC; n = 543). Patients who because of deteriorating hyperglycemia within 1 year required insulin therapy were considered as insulin requiring for survival (IRS; n = 743). Results The NIR patients had the highest age at onset (52 +/- 12 years; mean +/- SD), BMI (29.3 +/- 5.2 kg/m2) and C-peptide concentrations (median 0.98 nmol/l; interquartile range 0.72-1.31 nmol/l) but the lowest frequency of GAD antibodies (5.5%) compared to the IRC and IRS groups. The IRC group had a high age at onset (49 +/- 13 years), BMI (28.0 +/- 4.8 kg/m2), frequency of GAD antibodies (16.8%), intermediate C-peptide concentrations (0.56 nmol/l, interquartile range 0.28 +/- 0.94), and the highest prevalence of nephropathy (31.5%) and neuropathy (68.1%). The IRS group had the lowest age at onset (23 +/- 15 years), BMI (24.2 +/- 3.4 kg/m2), C-peptide concentrations (0.05 nmol/l, interquartile range below detection limit 0.01) and highest frequency of GAD antibodies (44.5%). Retinopathy was more common in IRS than in IRC patients (62.1 vs. 43.9%;p Conclusions The new WHO criteria seem to discrimin…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, given the strict HbA1c criteria for new-onset diabetes in the MHR and the fact that the NDR and Diabetes 2000 registers require a physician diagnosis according to established diagnostic criteria,28, 29 those classified as new-onset diabetes cases in our study are unlikely to be misclassified.”
From Plasma Copeptin and the Risk of Diabetes Mellitus (2010) · cites this paper as [29]
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423 · cited 1×
“5 mmol/1 [3].”
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
Marella, S., Maddirela, D. R., Badri, K. R., Jyothi Kumar, M. V., & Chippada, A. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373954 · Cited by 5,938
U.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
Tuomi, T., Carlsson, A., Li, H., Isomaa, B., Miettinen, A., Nilsson, A., Nissén, M., Ehrnström, B. O., Forsén, B., Snickars, B., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.1.150 · Cited by 502 · cited 3×
“The higher frequency of GAD antibodies would suggest admixture with the slowly progressing form of autoimmune diabetes also referred to as latent autoimmune diabetes in adults (LADA).”
MethodResultInfluentialSelf-citationVerge, C. F., Stenger, D., Bonifacio, E., Colman, P. G., Pilcher, C., Bingley, P. J., & Eisenbarth, G. S. (1998) · Diabetes · doi:10.2337/diabetes.47.12.1857 · Cited by 420
The DCCT Research Group (1986) · Diabetes · doi:10.2337/diab.35.5.530 · Cited by 331
Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect.
Lehto, M., Tuomi, T., Mahtani, M. M., Widén, E., Forsblom, C., Sarelin, L., Gullström, M., Isomaa, B., Lehtovirta, M., Hyrkkö, A., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119199 · Cited by 198 · cited 1×
“Many of these patients have subsequently been shown to carry mutations in MODY genes [9].”
BackgroundSelf-citationBorg, H., Marcus, C., Sjöblad, S., Fernlund, P., & Sundkvist, G. (2000) · Acta Paediatrica · doi:10.1080/080352500750029059 · Cited by 55 · cited 1×
“[11] showed that the GAD 41% of initially GADab positive children turned out to be negative after 3–7 years follow-up.”
BackgroundJaeger, C., Allendörfer, J., Hatziagelaki, E., Dyrberg, T., Bergis, K., Federlin, K., & Bretzel, R. (1997) · Hormone and Metabolic Research · doi:10.1055/s-2007-979091 · Cited by 36 · cited 1×
“[10], compatible with the presumption that GAD antibodies disappear with time.”
Research works printed but not linked: 1
- WHO Study Group (1985) in World Health Organization Technical Report Series 727 (World Health Organization, Geneva).
Cited by
Ahlqvist, E., Storm, P., Käräjämäki, A., Martinell, M., Dorkhan, M., Carlsson, A., Vikman, P., Prasad, R. B., Aly, D. M., Almgren, P., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30051-2 · Cited by 2,335
Self-citationMetabolite Profiling Identifies Pathways Associated With Metabolic Risk in Humans
Cheng, S., Rhee, E. P., Larson, M. G., Lewis, G. D., McCabe, E. L., Shen, D., Palma, M. J., Roberts, L. D., Dejam, A., Souza, A. L., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.067827 · Cited by 587
Postprandial Glucose Regulation and Diabetic Complications
Ceriello, A. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.19.2090 · Cited by 362
Orho-Melander, M., Melander, O., Guiducci, C., Perez-Martinez, P., Corella, D., Roos, C., Tewhey, R., Rieder, M. J., Hall, J., Abecasis, G., et al. (2008) · Diabetes · doi:10.2337/db08-0516 · Cited by 301
“In the Malmö Preventive Project (MPP), 33,346 citizens from Malmö in southern Sweden participated in a health screening during 1974–1992 (16).”
BackgroundInfluentialSelf-citationPlasma Copeptin and the Risk of Diabetes Mellitus
Enhörning, S., Wang, T. J., Nilsson, P. M., Almgren, P., Hedblad, B., Berglund, G., Struck, J., Morgenthaler, N. G., Bergmann, A., Lindholm, E., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.909663 · Cited by 299
Self-citation
Metadata
- Authors
- Lindholm, E., Agardh, E., Tuomi, T., Groop, L., & Agardh, C.-D.
- Venue
- European Journal of Epidemiology
- Published
- 2001-11
- Volume
- 17
- Issue
- 11
- Pages
- 983-989
- ISSN
- 0393-2990 (ISSN-L)
- 1573-7284
- OpenAlex
- W1960743603
- Semantic Scholar
- 8f224af55ca98bc4f9a0d8adc3d36176ebada5c7
- Cited by
- 82
- References
- 13
- Citations by year
- 2024: 5 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 1 · 2018: 9 · 2017: 5 · 2016: 6 · 2015: 3 · 2014: 8 · 2013: 2 · 2012: 12
- FWCI
- 0.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- European Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- diabetes mellitus, WHO clinical stage, insulin requirement, glutamic acid decarboxylase antibodies, C-peptide, age of onset, body mass index, diabetic nephropathy, diabetic neuropathy, diabetic retinopathy, disease severity classification
- MeSH terms
- Aged, Autoantibodies, C-Peptide, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Glutamate Decarboxylase, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Male, Middle Aged, Sweden, World Health Organization, Biomarkers, Guidelines as Topic, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Classifying diabetes according to the new WHO clinical stages. https://app.cochat.ai/papers/10.1023/a:1020036805655
- The paper
- Lindholm, E., Agardh, E., Tuomi, T., Groop, L., & Agardh, C.-D. (2001). Classifying diabetes according to the new WHO clinical stages. European Journal of Epidemiology. https://doi.org/10.1023/a%3A1020036805655
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.